Private Capital Markets
The private capital markets team carefully curates investment opportunities through raising capital for cutting-edge companies in the life sciences, medical technology and diagnostics sectors.
Brookline has a heritage of working with and sourcing investment opportunities from leading research institutions including Columbia University, Harvard University, Johns Hopkins University and Stanford University.
We have completed over 30 private capital markets transactions, raising in excess of $400 million as an Exclusive/Lead/Co-Placement Agent in the form of Convertible Notes and Convertible Preferred Stock.
The driving force behind Brookline's private placement model is its ability to raise capital for companies on a repeat basis. Since 2013, "repeat clients" have accounted for more than 50% of Brookline's business.